drugset / Trial / NCT00868010
Enhancing Rehabilitation After Stroke
Phase 3
Unknown
200 enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 12-week, randomized, placebo controlled study to determine if donepezil (Aricept) treatment during rehabilitation after stroke improves functional recovery.
Timeline
- Start
- 2009-03
- Primary completion
- 2013-08
- Completion
- 2013-11
Publications
- Background Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd JD, Goff DC, Hong Y, (2006): Heart Disease and Stroke Statistics-2006 Update, American Heart Association: February 14, 2006. http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.105.171600v1
- Background Whyte EM, Lenze EJ, Butters M, Skidmore E, Koenig K, Dew MA, Penrod L, Mulsant BH, Pollock BG, Cabacungan L, Reynolds CF 3rd, Munin MC. An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients. Cerebrovasc Dis. 2008;26(3):317-21. doi: 10.1159/000149580. Epub 2008 Jul 31.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 5 mg | — |
| Subject | Donepezil | Small molecule | 10 mg | — |